All posts by: Michael Zand

About Michael Zand

Expert highlights CRISPR’s applications, limitations, and ethical … – News-Medical.net

Continue reading

2017-08-02 NEWS

The Scientist

Expert highlights CRISPR’s applications, limitations, and ethical …
News-Medical.net
“Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the …
Scientists Destroy Entire Chromosome with CRISPR | The Scientist …The Scientist
Gene Editing Is Revolutionizing Medicine but Causing a …Newsweek
UC Berkeley to host conference on gene-editing technology …Xinhua
satPRnews (press release)
all 5 news articles »
Continue reading

2017-08-02 NEWS

Expert highlights CRISPR’s applications, limitations, and ethical concerns
News-Medical.net
“Good morning, doctor, I am here for my gene editing appointment.” In the future, could this be a greeting heard in physician offices around the world? With the introduction of CRISPR technology, genetic material can now be more easily and precisely

Continue reading

2017-08-01 NEWS

DOTmed.com

CRISPR – A spotlight on gene therapy and its potential role in personalized medicine
DOTmed.com
AACC invited Jennifer Doudna, professor of molecular and cellular biology at UC Berkley, to deliver the keynote speech, in which she addressed her work in CRISPR-mediated genome editing. Doudna has been featured in many scientific journals as well as …
YFV Protein, Middle East Markets, Gene Editing and “Data Lakes” are among Developments at First Day of AACC 2017 …Markets Insider

all 4 news articles »

Continue reading

2017-08-01 NEWS

FierceBiotech

Chiesi hands back gene therapy to uniQure
BioPharma Dive
Just months after uniQure N.V. announced it would not renew the market authorization for gene therapy Glybera in Europe, the company confirmed its partner Chiesi Farmaceutici is pulling out of another gene therapy agreement. The companies said Monday …
Chiesi Ends Collaboration with uniQure on Hemophilia B Gene Therapy CandidateGenetic Engineering & Biotechnology News
Uniqure from now on aloneEuropean Biotechnology

all 5 news articles »